These three dividend growth stocks are too boring to receive much attention from the financial media and analysts – and their yields aren’t necessarily going to generate much excitement among income seekers. But, come bear or bull, these stocks – including one pharma name that isn’t going to develop the first coronavirus vaccine but may well create what that vaccine comes in – can be “total-return machines” CLICK HERE.
